These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 11498370)

  • 1. Turning p53 on or off: either way may treat cancer.
    Fisher DE
    Drug Resist Updat; 2000 Apr; 3(2):77-79. PubMed ID: 11498370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy.
    Wiman KG
    Adv Cancer Res; 2007; 97():321-38. PubMed ID: 17419952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage.
    Kawamata H; Omotehara F; Nakashiro K; Uchida D; Shinagawa Y; Tachibana M; Imai Y; Fujimori T
    Int J Oncol; 2007 May; 30(5):1089-97. PubMed ID: 17390010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA; Lupu R
    Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional basis for therapeutic modulation of p53 signaling.
    Bassett EA; Wang W; Rastinejad F; El-Deiry WS
    Clin Cancer Res; 2008 Oct; 14(20):6376-86. PubMed ID: 18927276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptotic effect of celecoxib dependent upon p53 status in human ovarian cancer cells.
    Song YC; Kim SH; Juhnn YS; Song YS
    Ann N Y Acad Sci; 2007 Jan; 1095():26-34. PubMed ID: 17404014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
    Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
    Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53-based cancer therapies: Is defective p53 the Achilles heel of the tumor?
    Levesque AA; Eastman A
    Carcinogenesis; 2007 Jan; 28(1):13-20. PubMed ID: 17088261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enniatin exerts p53-dependent cytostatic and p53-independent cytotoxic activities against human cancer cells.
    Dornetshuber R; Heffeter P; Kamyar MR; Peterbauer T; Berger W; Lemmens-Gruber R
    Chem Res Toxicol; 2007 Mar; 20(3):465-73. PubMed ID: 17326668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-terminal peptides of p53 molecules enhance radiation-induced apoptosis in human mutant p53 cancer cells.
    Ohnishi K; Inaba H; Yasumoto J; Yuki K; Takahashi A; Ohnishi T
    Apoptosis; 2004 Sep; 9(5):591-7. PubMed ID: 15314287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p53 protein as a predictor of the response to 5-fluorouracil and cisplatin chemotherapy in human gastrointestinal cancer cell lines evaluated with apoptosis by use of thin layer collagen gel.
    Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
    Int J Oncol; 2004 Apr; 24(4):807-13. PubMed ID: 15010816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cells.
    Sun SY; Yue P; Chen X; Hong WK; Lotan R
    Cancer Res; 2002 Apr; 62(8):2430-6. PubMed ID: 11956107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of efficient apoptosis and cell-cycle arrest in tumor cells by adenovirus-mediated p53 A4 mutant.
    Maeda A; Nakamura S; Isono M; Osaki M; Ito H; Sato K
    Pathol Int; 2006 Mar; 56(3):126-34. PubMed ID: 16497245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
    Santoni-Rugiu E; Duro D; Farkas T; Mathiasen IS; Jäättelä M; Bartek J; Lukas J
    Oncogene; 2002 Sep; 21(42):6498-509. PubMed ID: 12226753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAK overexpression mediates p53-independent apoptosis inducing effects on human gastric cancer cells.
    Tong QS; Zheng LD; Wang L; Liu J; Qian W
    BMC Cancer; 2004 Jul; 4():33. PubMed ID: 15248898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line.
    Wu GS; Ding Z
    Oncogene; 2002 Jan; 21(1):1-8. PubMed ID: 11791171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
    Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
    Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome inhibitors as potential novel anticancer agents.
    Dou QP; Li B
    Drug Resist Updat; 1999 Aug; 2(4):215-223. PubMed ID: 11504494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.